Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Giovenzio, Genestreti"'
Autor:
Elisabetta Parisi, Giovenzio Genestreti, Anna Sarnelli, Giulia Ghigi, Donatella Arpa, Marco Angelo Burgio, Giampaolo Gavelli, Alice Rossi, Emanuela Scarpi, Manuela Monti, Anna Tesei, Rolando Polico, Antonino Romeo
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-10 (2019)
Abstract Background Concurrent chemotherapy and radiation using conventional fractionation is the standard treatment for inoperable, locally advanced non-small-cell lung cancer (NSCLC). We tested accelerated hypofractionated radiotherapy (AHR) and ch
Externí odkaz:
https://doaj.org/article/7654aced64d74a8cb58ba3f4623662c0
Autor:
Dario de Biase, Giovenzio Genestreti, Michela Visani, Giorgia Acquaviva, Monica Di Battista, Giovanna Cavallo, Alexandro Paccapelo, Alessandra Cancellieri, Rocco Trisolini, Roberta Degli Esposti, Stefania Bartolini, Annalisa Pession, Giovanni Tallini, Alba A Brandes
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177822 (2017)
BACKGROUND:Epidermal Growth Factor Receptor (EGFR) molecular analysis is performed to assess the responsiveness to Tyrosine Kinase Inhibitors (TKIs) in patients with Non-Small Cell Lung Cancer (NSCLC). The existence of molecular intra-tumoral heterog
Externí odkaz:
https://doaj.org/article/64653aa220bb440598c814e9ca1ee611
Publikováno v:
Journal of Cancer, Vol 3, Iss 1, Pp 241-245 (2012)
Purpose: Talc pleurodesis (TP) is employed worldwide for the management of persistent pneumothorax or pleural effusion, particularly of malignant origin. However, there are very little available data on 18F-fluorodeoxyglucose positron-emission tomogr
Externí odkaz:
https://doaj.org/article/b9df6a6078a34d7d8246f0d8e7309e3e
Autor:
Donatella Arpa, Anna Sarnelli, Manuela Monti, G. Ghigi, Marco Angelo Burgio, R. Polico, Antonino Romeo, Anna Tesei, Elisabetta Parisi, Giampaolo Gavelli, Giovenzio Genestreti, Emanuela Scarpi, Alice Rossi
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-10 (2019)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background Concurrent chemotherapy and radiation using conventional fractionation is the standard treatment for inoperable, locally advanced non-small-cell lung cancer (NSCLC). We tested accelerated hypofractionated radiotherapy (AHR) and chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dda31eabf3fbf8a045df4ef2f17fe4d4
http://link.springer.com/article/10.1186/s13014-019-1317-x
http://link.springer.com/article/10.1186/s13014-019-1317-x
Autor:
Chiara Arienti, Stefano Sanna, Donatella Arpa, P. Bovolato, Emanuela Scarpi, G. Ghigi, Antonino Romeo, Elisa Neri, Christian Gurioli, S.R. Bellia, Giovenzio Genestreti, Simona Micheletti, B. Dipalma, F. Rea, R. Polico, G. Storme, G. Furini, Anna Tesei, Elisabetta Parisi, Anna Sarnelli, Marco Angelo Burgio
Publikováno v:
Cancer/Radiothérapie. 21:766-773
Purpose The role played by radiation therapy after pleurectomy/decortication or surgical biopsy in malignant pleural mesothelioma is uncertain. We treated patients with accelerated hypofractionated radiotherapy using helical tomotherapy and intensity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa359f5ac0c4cafb41670fcdac580916
https://doi.org/10.1016/j.canrad.2017.05.007
https://doi.org/10.1016/j.canrad.2017.05.007
New Drugs in the Treatment of Elderly Patients with Metastatic Castration-Resistance Prostate Cancer
Publikováno v:
Tumori Journal. 102:361-366
Treatment of prostate cancer is continually evolving and new therapies have become available. However, the management of elderly patients is challenging due to their age and comorbidities. Androgen deprivation therapy remains the mainstay treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::153bffd15a8af4ed8b9ece6094ad7d56
https://doi.org/10.5301/tj.5000508
https://doi.org/10.5301/tj.5000508
Autor:
Claudia Mucciarini, M L Barzelloni, Olga Martelli, Orazio Caffo, Antonio Rossi, Alessandro Follador, V. Filipazzi, Massimo Di Maio, Pier Luigi Piovano, Alessandra Bearz, Erika Rijavec, Giuseppe Luigi Banna, Giovenzio Genestreti, Fausto Barbieri, Tiziana Vavalà, Nicoletta Zilembo, Alessandro Morabito, Diego Cortinovis, Silvia Novello, F.L. Cecere, Marcello Tiseo, Elisa Rizzo, C. Casartelli, Jessica Menis, Emilio Bria, Domenico Galetta, Gianluca Spitaleri, Antonio Ardizzoia
Publikováno v:
Lung Cancer. 95:73-81
Objectives Non-small-cell-lung-cancer (NSCLC) patients harbouring epidermal growth factor receptor (EGFR) mutations develop drug resistance after 9–12 months of EGFR tyrosine kinase inhibitors (TKIs) therapy pointing out the issue of the second-lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::475e5ac2fb5acebb846af7e74a0a89ba
https://doi.org/10.1016/j.lungcan.2016.02.011
https://doi.org/10.1016/j.lungcan.2016.02.011
Autor:
Michela Visani, Dario de Biase, Giovanna Cavallo, Giovanni Tallini, Giorgia Acquaviva, Alba A. Brandes, Giovenzio Genestreti, Roberta Degli Esposti, Monica Di Battista, Thomas Brand, Annalisa Pession
Publikováno v:
Clinical Lung Cancer. 18:e215-e217
Clinical Practice Points • p.E749Q is an uncommon EGFR mutation in exon 19 with unknown clinical significance. • A patient with lung adenocarcinoma harboring the p.E749Q EGFR mutation does not respond to gefitinib. • The p.E749Q mutation seems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6881a2e18f7e81e31281dc84f96e9d55
https://doi.org/10.1016/j.cllc.2017.01.003
https://doi.org/10.1016/j.cllc.2017.01.003
Autor:
Giovanna Cavallo, Hirotsugu Kenmotsu, Federica Carloni, Emanuela Scarpi, Raffaele Califano, Marco Angelo Burgio, Claudia Casanova, Alberto Bongiovanni, Seber Selcuk, Monica Di Battista, Kurup Roopa, Giulio Metro, Wakuda Kazushige, Giovenzio Genestreti, Taner Korkmaz, Marcello Tiseo
Publikováno v:
Clinical Lung Cancer. 16:e223-e228
Small-cell lung cancer has a high chemotherapeutic sensitivity but with disappointing outcome results. Patients with “sensitive disease” are those who respond to treatment with a long relapse-free interval (RFI): in these cases rechallenge with f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::747103dfee6627e483beb8592dca9d97
https://doi.org/10.1016/j.cllc.2015.04.006
https://doi.org/10.1016/j.cllc.2015.04.006
Autor:
Giovanna Cavallo, De Biase D, Giorgia Dalpiaz, Bartolotti M, Valli M, Alba A. Brandes, Giovenzio Genestreti, Rocco Trisolini, Lazzari-Agli La, Di Battista M, Denicolò F
Publikováno v:
Tumori Journal. 101:e92-e95
Background Pulmonary toxicity is a well-known complication observed with several anticancer drugs. Docetaxel, a taxane chemotherapy drug widely used in the treatment of many types of solid tumors including non-small cell lung cancer (NSCLC), rarely c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a2d201e315bf18a388e278ca2d914d9
https://doi.org/10.5301/tj.5000275
https://doi.org/10.5301/tj.5000275